GJA1 and central nervous system disorder: Here, we showed that activation of JNK by LPS contributes to a reduction of Cx43 expression and GJIC in astrocytes via ubiquitin-proteasome pathway, suggesting that inhibition of JNK signaling cascades may provide therapeutic benefit in the development of CNS disorders.